FundingHealthcare & Life Sciences
Ultrahuman raises $70 mn to expand health platform
By Abha Lohia · Editor ·
Ultrahuman: revenue and funding and every story →
BengaluruFounded 2019
- Ultrahuman builds wearable devices and software that track sleep, metabolic health, fitness, and blood biomarkers
- The company raised $70 million in a new funding round led by Qualcomm Ventures with participation from Labcorp and others
- The fresh capital will accelerate research and development across sensing, artificial intelligence, and clinical science
What happened
- Wearable technology company Ultrahuman raised $70 million in new financing to expand its health intelligence platform.
- The funding round was led by Qualcomm Ventures with participation from Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital.
- The company plans to use the capital to accelerate research and development across sensing, artificial intelligence [computer systems able to perform tasks typically requiring human intelligence], miniaturised electronics, and clinical science.
- Ultrahuman aims to evolve from a wearable health company into a human-computer interface company built around physiological data from the human body.
- The company's ecosystem includes the Ultrahuman Ring, Blood Vision blood testing, continuous glucose monitoring devices, and the Jade real-time biointelligence system.
- The funding follows strong financial growth, with the company reporting revenue of Rs 565 crore and a profit after tax of Rs 73 crore for the fiscal year ended March 2025.
Why it matters
- The financing comes as Ultrahuman works to rebuild its presence in the United States following a patent dispute with Finnish rival Oura that led to an import ban on its smart rings.
The business
- Ultrahuman develops hardware and software products to track sleep, fitness, reproductive cycles, and blood markers to enhance healthspan and longevity.
- Its flagship hardware products include the Ultrahuman Ring AIR and the newer pre-order Ultrahuman Ring PRO.
- The company offers continuous glucose monitoring sensors such as M1 and M2 Live to track real-time glucose levels.
- Blood Vision decodes over 100 blood markers into supplement plans and lifestyle tips.
- The business generates revenue from device sales as well as a high-margin software subscription business that includes features like Cycle & Ovulation Pro and AFib Detection.
The founders
- Co-founded Ultrahuman in 2019.
- Previously co-founded logistics startup Runnr, which was acquired by Zomato in 2017.
- Co-founded Ultrahuman in 2019.
- Previously co-founded logistics startup Runnr, which was acquired by Zomato in 2017.
Who put in money
- Qualcomm Ventures lead — Venture capital arm of Qualcomm Technologies
- Labcorp participated — Laboratory Corporation of America
- Alpha Wave participated
- Blume Ventures participated
- Nexus Venture Partners participated
- Alteria Capital participated
In numbers
$64 millionFY25 operating revenue · 2025
$8.2 millionFY25 net profit · 2025
Rs 565 croreFY25 revenue in rupees · 2025
Rs 73 croreFY25 profit after tax · 2025
What happens next
- Expand health technology platform and global presence
- Accelerate research and development across sensing, artificial intelligence, and clinical science
Earlier rounds
- 2025-11 · Venture Debt · Rs 100 crore · led by Alteria Capital
- 2022-10 · Series B · $35 million
- 2022-10 · Series A · $17.5 million
Up against
OuraTempleRingConn
In their words
“For the longest time, computers have understood almost everything about the world except the person using them. We want to change that.”Mohit Kumar, Founder and CEO
“The future of AI is personal, ambient, and always on. Ultrahuman is pioneering a new generation of personal AI devices that make personalized insights effortless.”Quinn Li, Senior Vice President, Qualcomm Technologies, and Global Head of Qualcomm Ventures
Words to know
- human-computer interface
- technology that allows a computer system to understand and interact directly with human physiological data and signals
- continuous glucose monitoring
- wearable sensor technology that tracks glucose levels continuously throughout the day and night
- biomarkers
- measurable indicators of the severity or presence of some disease state or physiological property
The numbers around it
Healthcare & Life Sciences in September 2026: 11 rounds with a disclosed amount, $114 million in all; the biggest was Ultrahuman ($70 mn). Every sector this year →
Other articles talking about it
Business Standard ↗medianama ↗ascendants.in ↗Indian Startup News ↗Moneycontrol ↗Entrackr ↗Times of India Business ↗startup-story-media ↗Entrackr ↗Inc42 ↗Inc42 ↗
Terms in this story
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
- Medical device vs wellness wearable: In India a health wearable is treated as a medical device when its maker says it can diagnose, monitor, treat or prevent a disease. A gadget sold only for general fitness or wellness sits outside those rules, but its claims are still policed by consumer law.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on Ultrahuman → · All startup news on 1 September 2026 →
Is this Ultrahuman? Get your “Featured on StopDown” badge →